Related Experiment Video
Updated: Jun 18, 2025
05:33
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
1.4K
Immunotherapy in melanoma: advances, pitfalls, and future perspectives
Cristina Sorino1, Simona Iezzi1, Ludovica Ciuffreda1
1SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
Frontiers in Molecular Biosciences
|August 1, 2024
Summary
Immunotherapy has revolutionized melanoma treatment, but challenges like resistance and side effects persist. Understanding the tumor microenvironment is key to improving melanoma immunotherapy efficacy and developing new biomarkers.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Cutaneous melanoma is an aggressive skin cancer with high metastatic potential.
- Targeted therapies and immunotherapy have improved melanoma patient outcomes.
- Current treatments face limitations due to side effects and resistance mechanisms.
Purpose of the Study:
- To review current immunotherapeutic strategies for melanoma.
- To analyze the role of the tumor microenvironment in immunotherapy response.
- To identify areas for improvement in melanoma treatment and biomarker discovery.
Main Methods:
- Literature review of current immunotherapeutic strategies for melanoma.
- Analysis of the interplay between the tumor microenvironment and the immune system.
- Examination of melanoma immune evasion mechanisms.
Main Results:
- Immunotherapy and targeted therapies have significantly improved melanoma survival and quality of life.
- Tumor microenvironment critically influences immunotherapy responsiveness and efficacy.
- Melanoma cells employ various mechanisms for immune evasion.
Conclusions:
- Further understanding of tumor microenvironment interactions is crucial for enhancing melanoma immunotherapy.
- Identifying predictive biomarkers is essential for optimizing treatment selection.
- Improved therapeutic strategies are needed to overcome resistance and reduce side effects in melanoma management.
Related Concept Videos
01:27Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:30Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K